Explore more publications!

Press Releases

ForaCare Joins athenahealth’s Marketplace Program to Expand RPM, CCM, and RTM Access to Healthcare Providers
SafeSpace Global Corporation Reports Q2 Fiscal 2026 Financial Results; Company Transitions from Pre-Revenue to Revenue-Generating Stage, Expands Footprint with Nashville Office, and Initiates Steps Toward National Exchange Uplisting
Bronstein, Gewirtz & Grossman LLC Urges Driven Brands Holdings Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
Minerva Valuations Expands Presence Across Key North American Financial Hubs, Backed by Recent Transaction Execution
Diana Shipping Inc. Comments on Genco Shipping & Trading Rejection of Diana’s Increased Offer to Acquire Genco, Made in Partnership with Star Bulk Carriers
DHT Holdings, Inc. has filed Form 20-F for 2025 with the U.S. Securities and Exchange Commission
Cloudastructure Inc. Schedules Fourth Quarter 2025 Financial Results and Business Update Conference Call
Grand Rapids Housing Market Outperforms National Trends as Midwest Leads U.S.
PYPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in PayPal Holdings, Inc. Securities Lawsuit — The Gross Law Firm
Picard Medical / SynCardia to Present its Next-Generation Emperor Total Artificial Heart Technology at the American College of Cardiology’s Annual Scientific Session
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET
Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue…
Remarks by Chair Atkins on the SEC’s Regulatory Philosophy and Policy Agenda

Remarks by Chair Atkins on the SEC’s Regulatory Philosophy and Policy Agenda

Lunai Bioworks Engages Initial U.S. Countermeasure Opportunities Following $400M–$1.2B Consortium Launch
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT
Bonchon Appoints Industry Veteran Blas Escarcega as Chief Development Officer to Accelerate U.S. Growth
Arch Biopartners Announces St. Michael’s Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide
New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease
BitFuFu Announces Unaudited 2025 Full-Year Financial Results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions